Fargo Biotech Firm is a Global Leader in Finding Antibodies and Turning Them Into New Drugs

Genovac, recently spun off from Aldevron, has clients in North America, Europe, Australia and Asia. The firm has technology that enables rapid antibody screening and development of drugs to fight infectious diseases, including COVID-19.

Article written by Patrick Springer for INFORUM, April 26, 2021.

To read the article in full click here (subscription service)